Cyclodextrins in antiviral therapeutics and vaccines

33Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.

Abstract

The present review describes the various roles of cyclodextrins (CDs) in vaccines against viruses and in antiviral therapeutics. The first section describes the most commonly studied application of cyclodextrins-solubilisation and stabilisation of antiviral drugs; some examples also refer to their beneficial taste-masking activity. The second part of the review describes the role of cyclodextrins in antiviral vaccine development and stabilisation, where they are employed as adjuvants and cryopreserving agents. In addition, cyclodextrin-based polymers as delivery systems for mRNA are currently under development. Lastly, the use of cyclodextrins as pharmaceutical active ingredients for the treatment of viral infections is explored. This new field of application is still taking its first steps. Nevertheless, promising results from the use of cyclodextrins as agents to treat other pathologies are encouraging. We present potential applications of the results reported in the literature and highlight the products that are already available on the market.

Cite

CITATION STYLE

APA

Braga, S. S., Barbosa, J. S., Santos, N. E., El-Saleh, F., & Paz, F. A. A. (2021). Cyclodextrins in antiviral therapeutics and vaccines. Pharmaceutics, 13(3). https://doi.org/10.3390/pharmaceutics13030409

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free